The Bayh-Dole Act: Issues, Concerns and Conflicts Out of Stock
The Bayh-Dole Act, a cornerstone of the academic research enterprise, has been one of the most significant forces to advance the commercialization of research. In late 2003 and throughout 2004, the Bayh-Dole Act received considerable attention when public interest groups requested that Abbott Laboratories lower the price of a popular drug and questioned the rights and responsibilities of the government under the act because the drug was sponsored in part with federal research and development dollars. The ensuing debate raised questions about research relationships and the policies and practices involved in the academic government-industrial triad.
Additional Product Photos
Our system is currently down for scheduled maintenance. Your member services will be available again shortly. Please check back soon.